logo
Select company
Select metric
$ 127KCapital Expenditure
VS
Market
79
Sector
61
Industry
48
History
42
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

YMAB

Company Name

Y-MABS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Y-MABS THERAPEUTICS INC - Capital Expenditure Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

YMAB - CapEx Historical data
DateCapital Expenditure
6/30/2025$ 127K
3/31/2025$ 127K
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • Y-MABS THERAPEUTICS INC's latest trailing twelve months (TTM) CapEx stands at $ 1.28M.
  • Over the past 5 years, Y-MABS THERAPEUTICS INC's average CapEx has been $ -12.17M.
  • The median CapEx for Y-MABS THERAPEUTICS INC during this period was $ 0
  • Y-MABS THERAPEUTICS INC reached its highest CapEx over the past 5 years at $ 1.28M.
  • The lowest CapEx recorded by Y-MABS THERAPEUTICS INC in the same timeframe $ -61.46M

Y-MABS THERAPEUTICS INC's CapEx vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx Benchmarks
CompanyCapEx
ADCT : ADC THERAPEUTICS SA $ 570KNKTR : NEKTAR THERAPEUTICS $ -64.22MKURA : KURA ONCOLOGY INC $ 2.12MLXRX : LEXICON PHARMACEUTICALS INC $ 781KTRDA : ENTRADA THERAPEUTICS INC $ 2.69MXOMA : XOMA ROYALTY CORP $ 9.46MSAGE : SAGE THERAPEUTICS INC $ 0CDXS : CODEXIS INC $ 6.47MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ 217KSGMO : SANGAMO THERAPEUTICS INC $ 291K

Definition of Capital Expenditure

[Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.

YMAB - Capital Expenditure, Last 5 years

$ -61.46M

Minimum

Mar 31, 2021

$ 1.28M

Maximum

Sep 30, 2020

$ -12.17M

Average

$ 0

Median

CapEx Benchmark Analysis

The chart above depicts the distribution of CapEx for companies in the Total Stock Market. The average CapEx of the companies is $ 9.65M with a standard deviation of $ 15.86M.
The following table provides additional summary stats:
CapEx in the Market:
filtered constituents2.92K
min$ -41.06M
max$ 63.78M
average$ 9.65M
median$ 1.92M
std$ 15.86M